Single-center Retrospective Study : Developmental Trajectories of Children Born Prematurely Before 32 Weeks Assessed With the Revised Brunet Lézine Scale at 1, 2 and 3 Years
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Créteil, France, 94000
- Chi Creteil
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Children born at CHI Créteil between 2012 and 2022, included in the Val de Marne perinatal network.
- Children seen in pediatrician-psychomotor consultation with assessment by the BLR scale at 1 year AC.
Exclusion Criteria:
- Children born with a term of birth ≥ 32 weeks + 1 day.
- Child removed from the Val de Marne perinatal network monitoring from the age of 1 year AC: Death or parental decision.
- Children presenting with cerebral palsy, blindness or deafness at the age of 1 year AC.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Overall DQ obtained on the BLR scale at 1, 2 and 3 years, collected by the psychomotor therapists at CHI Créteil.
Time Frame: 1, 2 and 3 years
|
1, 2 and 3 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Analysis of the 4 sub-scores (movement and posture, language, socialization, coordination) obtained on the BLR scale at 1, 2 and 3 years, collected by the psychomotor therapists at CHI Créteil.
Time Frame: 1,2 and 3 years
|
1,2 and 3 years
|
|
Analysis of family socio-demographic data : level of education
Time Frame: 1,2 and 3 years
|
1,2 and 3 years
|
|
Analysis of family socio-demographic data : age of parents
Time Frame: 1,2 and 3 years
|
1,2 and 3 years
|
|
Analysis of birth data : term
Time Frame: 1, 2 and 3 years
|
1, 2 and 3 years
|
|
Analysis of birth data : weight
Time Frame: 1,2 and 3 years
|
1,2 and 3 years
|
|
Analysis of duration of hospitalization
Time Frame: 1,2 and 3 years
|
1,2 and 3 years
|
|
Evaluate the concordance of BLR scale at 5 years with the measurement scores (not validated) used by the Val de Marne perinatal network (and all the Ile de France perinatal networks) filed out during the same consultations
Time Frame: 5 years
|
5 years
|
|
Evaluate the concordance of BLR scale at 5 years with the measurement scores (not validated) used by the Val de Marne perinatal network (and all the Ile de France perinatal networks) filed out during the same consultations
Time Frame: 1,2 and 3 years
|
1,2 and 3 years
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- PREMADEV
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.